2,551
Views
25
CrossRef citations to date
0
Altmetric
Review

Acute myeloid leukemia and NK cells: two warriors confront each other

, &
Article: e1539617 | Received 17 Aug 2018, Accepted 10 Oct 2018, Published online: 31 Oct 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Thunyamon Chajuwan, Patsita Kansuwan, Sirorat Kobbuaklee & Chantiya Chanswangphuwana. (2022) Characteristics and clinical correlation of TIM-3 and PD-1/PD-L1 expressions in leukemic cells and tumor microenvironment in newly diagnosed acute myeloid leukemia. Leukemia & Lymphoma 63:2, pages 450-456.
Read now
Siyu Yang, Xiaojiao Yin, Ying Yue & Siqing Wang. (2019) Application Of Adoptive Immunotherapy In Ovarian Cancer. OncoTargets and Therapy 12, pages 7975-7991.
Read now

Articles from other publishers (23)

SASSINE GHANEM, ZAID ABDEL RAHMAN, LANA KHALIL, MAY DAHER & PAUL LIN. 2024. Manual of Hematopoietic Cell Transplantation and Cellular Therapies. Manual of Hematopoietic Cell Transplantation and Cellular Therapies 403 410 .
Mehdi Bakhtiyaridovvombaygi, Somayeh Yazdanparast, Fatemeh Mikanik, Amirhossein Izadpanah, Sahar Parkhideh, Amin Shahbaz ghasabeh, Elham Roshandel, Abbas Hajifathali & Ahmad Gharehbaghian. (2023) Cytokine‐Induced Memory‐Like NK Cells: Emerging strategy for AML immunotherapy. Biomedicine & Pharmacotherapy 168, pages 115718.
Crossref
Yiying Zhu, Zhangxun Zhao, Minggao Xue, Dan Wang, Guifeng Su, Xiaoman Ju, Qihong Yang, Shaohua Zhang, Dongmei Fan, Huifang Zhu, Min Yu, Yan Li, Lingmei Kong & Hongyu Zhou. (2023) Ciclopirox olamine sensitizes leukemia cells to natural killer cell-mediated cytolysis by upregulating NKG2DLs via the Akt signaling pathway. Biochemical and Biophysical Research Communications 659, pages 10-19.
Crossref
Erden Atilla & Karim Benabdellah. (2023) The Black Hole: CAR T Cell Therapy in AML. Cancers 15:10, pages 2713.
Crossref
Selma Z. D’Silva, Meenakshi Singh & Andrea S. Pinto. (2023) NK cell defects: implication in acute myeloid leukemia. Frontiers in Immunology 14.
Crossref
Yasmina Serroukh, Josée Hébert, Lambert Busque, François Mercier, Christopher E. Rudd, Sarit Assouline, Silvy Lachance & Jean-Sébastien Delisle. (2023) Blasts in context: the impact of the immune environment on acute myeloid leukemia prognosis and treatment. Blood Reviews 57, pages 100991.
Crossref
Qi-Hui Xie, Ji-Qi Zheng, Jia-Yi Ding, Yu-Fei Wu, Luisa Liu, Zi-Li Yu & Gang Chen. (2022) Exosome-Mediated Immunosuppression in Tumor Microenvironments. Cells 11:12, pages 1946.
Crossref
Hamidreza Ebrahimiyan, Amirhossein Tamimi, Bahareh Shokoohian, Neda Minaei, Arash Memarnejadian, Nikoo Hossein-Khannazer, Moustapha Hassan & Massoud Vosough. (2022) Novel insights in CAR-NK cells beyond CAR-T cell technology; promising advantages. International Immunopharmacology 106, pages 108587.
Crossref
Guanfang Liu, Qi Zhang, Jingying Yang, Xiaomin Li, Luhua Xian, Wenmin Li, Ting Lin, Juan Cheng, Qiwen Lin, Xiuzhang Xu, Qin Li, Yu Lin, Maohua Zhou & Erxia Shen. (2021) Increased TIGIT expressing NK cells with dysfunctional phenotype in AML patients correlated with poor prognosis. Cancer Immunology, Immunotherapy 71:2, pages 277-287.
Crossref
Guneet Kaleka & Gary Schiller. (2022) Immunotherapy for Acute Myeloid Leukemia: Allogeneic hematopoietic cell transplantation is here to stay. Leukemia Research 112, pages 106732.
Crossref
Zhicheng Du, Yu Yang Ng, Shijun Zha & Shu Wang. (2021) piggyBac system to co-express NKG2D CAR and IL-15 to augment the in vivo persistence and anti-AML activity of human peripheral blood NK cells. Molecular Therapy - Methods & Clinical Development 23, pages 582-596.
Crossref
Débora Bifano Pimenta, Vanessa Araujo Varela, Tarcila Santos Datoguia, Victória Bulcão Caraciolo, Gabriel Herculano Lopes & Welbert Oliveira Pereira. (2021) The Bone Marrow Microenvironment Mechanisms in Acute Myeloid Leukemia. Frontiers in Cell and Developmental Biology 9.
Crossref
Yang Xiao, Jinghong Chen, Jia Wang, Wei Guan, Mengzhen Wang, Linlin Zhang, Zhiding Wang, Lixin Wang & Li Yu. (2021) Acute Myeloid Leukemia Epigenetic Immune Escape From Nature Killer Cells by ICAM-1. Frontiers in Oncology 11.
Crossref
Faroogh Marofi, Marwan Mahmood Saleh, Heshu Sulaiman Rahman, Wanich Suksatan, Moaed E. Al-Gazally, Walid Kamal Abdelbasset, Lakshmi Thangavelu, Alexei Valerievich Yumashev, Ali Hassanzadeh, Mahboubeh Yazdanifar, Roza Motavalli, Yashwant Pathak, Adel Naimi, Behzad Baradaran, Marzieh Nikoo & Farhad Motavalli Khiavi. (2021) CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies. Stem Cell Research & Therapy 12:1.
Crossref
Natasha Mupeta Kaweme & Fuling Zhou. (2021) Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment. Frontiers in Immunology 12.
Crossref
Zhenhui Wu, Huan Zhang, Min Wu, Guorui Peng, Yanqiu He, Na Wan & Yingjian Zeng. (2021) Targeting the NKG2D/NKG2D-L axis in acute myeloid leukemia. Biomedicine & Pharmacotherapy 137, pages 111299.
Crossref
Hind Rafei, May Daher & Katayoun Rezvani. (2020) Chimeric antigen receptor (CAR) natural killer (NK)‐cell therapy: leveraging the power of innate immunity. British Journal of Haematology 193:2, pages 216-230.
Crossref
Alena Machuldova, Monika Holubova, Valentina S. Caputo, Miroslava Cedikova, Pavel Jindra, Lucie Houdova & Pavel Pitule. (2021) Role of Polymorphisms of NKG2D Receptor and Its Ligands in Acute Myeloid Leukemia and Human Stem Cell Transplantation. Frontiers in Immunology 12.
Crossref
May Daher & Katayoun Rezvani. (2021) Outlook for New CAR-Based Therapies with a Focus on CAR NK Cells: What Lies Beyond CAR-Engineered T Cells in the Race against Cancer. Cancer Discovery 11:1, pages 45-58.
Crossref
Jing Xu & Ting Niu. (2020) Natural killer cell-based immunotherapy for acute myeloid leukemia. Journal of Hematology & Oncology 13:1.
Crossref
Dongfang Liu, Saiaditya Badeti, Gianpietro Dotti, Jie-gen Jiang, He Wang, James Dermody, Patricia Soteropoulos, Deanna Streck, Raymond B. Birge & Chen Liu. (2020) The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy. Cell Communication and Signaling 18:1.
Crossref
Samantha L. Smith, Philippa R. Kennedy, Kevin B. Stacey, Jonathan D. Worboys, Annie Yarwood, Seungmae Seo, Everardo Hegewisch SolloaBrandon Mistretta, Sujash S. Chatterjee, Preethi Gunaratne, Kimaada Allette, Ying-Chih Wang, Melissa Laird Smith, Robert Sebra, Emily M. Mace, Amir Horowitz, Wendy Thomson, Paul Martin, Steve Eyre & Daniel M. Davis. (2020) Diversity of peripheral blood human NK cells identified by single-cell RNA sequencing. Blood Advances 4:7, pages 1388-1406.
Crossref
Barbara L. Kee, Rosmary E. Morman & Mengxi Sun. 2020. 1 28 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.